Nifty
:
24273.80
Sensex
:
80334.81
-140.60 (-0.58%)
-411.97 (-0.51%)
Nifty
Sensex
:
:
24273.80
80334.81
-140.60 (-0.58%)
-411.97 (-0.51%)

Wanbury Ltd.

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 524212 | NSE: WANBURY

NSE BSE
243.81
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  233.49
  •  261.26
  •  230.00
  •  226.73
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  574565
  •  1424.46
  •  323.53
  •  131.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 756.51
  • 17.23
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 920.32
  • N/A
  • 18.92

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 39.76%
  • 8.97%
  • 41.78%
  • FII
  • DII
  • Others
  • 1.55%
  • 0.00%
  • 7.94%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.70
  • 9.39
  • 4.04

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.57
  • -
  • 17.14

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 33.13
  • -2.79
  • -11.77

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 2.57
  • 12.01

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -0.47
  • -0.56
  • 0.22

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.82
  • 12.90
  • 9.86

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
133.45
145.50
-8.28%
161.19
144.46
11.58%
131.11
146.28
-10.37%
139.41
132.97
4.84%
Expenses
119.51
124.35
-3.89%
141.18
127.12
11.06%
120.13
132.94
-9.64%
121.24
118.81
2.05%
EBITDA
13.95
21.15
-34.04%
20.01
17.34
15.40%
10.97
13.35
-17.83%
18.16
14.16
28.25%
EBIDTM
10.45%
14.53%
12.41%
12.01%
8.37%
9.12%
13.03%
10.65%
Other Income
0.84
0.69
21.74%
1.63
0.76
114.47%
0.95
0.62
53.23%
0.93
-2.06
-
Interest
10.17
8.26
23.12%
10.15
7.67
32.33%
7.59
5.79
31.09%
7.46
7.52
-0.80%
Depreciation
3.32
3.32
0.00%
3.32
3.24
2.47%
3.29
3.19
3.13%
3.28
3.07
6.84%
PBT
1.29
10.25
-87.41%
8.17
7.19
13.63%
1.04
4.99
-79.16%
33.91
0.92
3,585.87%
Tax
0.07
-0.02
-
0.15
-0.18
-
0.00
0.30
-100.00%
0.27
-0.10
-
PAT
1.22
10.27
-88.12%
8.02
7.36
8.97%
1.04
4.69
-77.83%
33.63
1.02
3,197.06%
PATM
0.91%
7.06%
4.97%
5.10%
0.79%
3.21%
24.13%
0.76%
EPS
0.37
3.14
-88.22%
2.45
2.25
8.89%
0.32
1.43
-77.62%
10.27
0.31
3,212.90%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
565.16
575.65
499.65
511.19
392.52
367.45
391.37
371.10
433.81
423.26
249.92
Net Sales Growth
-0.71%
15.21%
-2.26%
30.23%
6.82%
-6.11%
5.46%
-14.46%
2.49%
69.36%
 
Cost Of Goods Sold
280.58
302.63
303.44
300.28
221.33
175.74
196.20
174.09
196.97
182.40
119.30
Gross Profit
284.58
273.02
196.20
210.90
171.19
191.72
195.17
197.01
236.83
240.87
130.62
GP Margin
50.35%
47.43%
39.27%
41.26%
43.61%
52.18%
49.87%
53.09%
54.59%
56.91%
52.26%
Total Expenditure
502.06
505.65
476.57
479.45
376.85
389.07
378.00
439.03
415.28
390.89
228.50
Power & Fuel Cost
-
24.58
20.59
18.41
17.13
15.38
14.46
15.26
18.74
18.51
10.05
% Of Sales
-
4.27%
4.12%
3.60%
4.36%
4.19%
3.69%
4.11%
4.32%
4.37%
4.02%
Employee Cost
-
86.92
81.00
74.81
64.15
67.48
75.72
87.10
87.59
85.41
39.57
% Of Sales
-
15.10%
16.21%
14.63%
16.34%
18.36%
19.35%
23.47%
20.19%
20.18%
15.83%
Manufacturing Exp.
-
13.31
11.43
12.66
9.98
13.77
7.98
10.21
15.04
12.34
2.98
% Of Sales
-
2.31%
2.29%
2.48%
2.54%
3.75%
2.04%
2.75%
3.47%
2.92%
1.19%
General & Admin Exp.
-
26.59
22.72
20.58
23.63
28.56
30.47
29.66
34.37
29.80
25.49
% Of Sales
-
4.62%
4.55%
4.03%
6.02%
7.77%
7.79%
7.99%
7.92%
7.04%
10.20%
Selling & Distn. Exp.
-
26.65
21.27
31.31
16.86
19.63
27.41
29.49
42.43
34.19
15.15
% Of Sales
-
4.63%
4.26%
6.12%
4.30%
5.34%
7.00%
7.95%
9.78%
8.08%
6.06%
Miscellaneous Exp.
-
24.96
16.12
21.40
23.78
68.51
25.77
93.22
20.14
28.26
15.15
% Of Sales
-
4.34%
3.23%
4.19%
6.06%
18.64%
6.58%
25.12%
4.64%
6.68%
6.39%
EBITDA
63.09
70.00
23.08
31.74
15.67
-21.62
13.37
-67.93
18.53
32.37
21.42
EBITDA Margin
11.16%
12.16%
4.62%
6.21%
3.99%
-5.88%
3.42%
-18.31%
4.27%
7.65%
8.57%
Other Income
4.35
2.99
1.01
5.09
4.75
46.20
11.50
76.70
89.69
1.40
6.48
Interest
35.37
29.18
21.39
20.61
23.07
32.87
39.88
30.86
35.51
31.87
18.62
Depreciation
13.21
13.03
12.38
11.45
9.75
9.68
9.97
10.30
10.32
9.05
4.80
PBT
44.41
30.78
-9.69
4.76
-12.41
-17.97
-24.98
-32.39
62.40
-7.15
4.48
Tax
0.49
0.38
0.11
-0.35
0.20
0.21
-0.14
-0.38
0.38
0.00
1.27
Tax Rate
1.10%
0.67%
-1.07%
-0.43%
-1.61%
0.32%
0.56%
1.17%
0.61%
0.00%
28.35%
PAT
43.91
55.96
-10.40
81.47
-12.61
64.46
-24.85
-32.01
62.01
-7.15
3.20
PAT before Minority Interest
43.91
55.96
-10.40
81.47
-12.61
64.46
-24.85
-32.01
62.01
-7.15
3.20
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
7.77%
9.72%
-2.08%
15.94%
-3.21%
17.54%
-6.35%
-8.63%
14.29%
-1.69%
1.28%
PAT Growth
88.13%
-
-
-
-
-
-
-
-
-
 
EPS
13.39
17.06
-3.17
24.84
-3.84
19.65
-7.58
-9.76
18.91
-2.18
0.98

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
27.94
-32.82
-23.42
-156.24
-143.45
-209.28
-184.68
-153.28
-188.77
-193.94
Share Capital
32.75
32.71
32.67
25.02
25.00
23.72
23.72
23.22
19.97
19.97
Total Reserves
-11.64
-67.15
-57.01
-181.60
-168.66
-233.23
-208.66
-176.50
-220.96
-213.91
Non-Current Liabilities
95.95
10.81
10.56
84.43
107.74
130.36
105.79
159.92
251.37
298.18
Secured Loans
82.00
0.00
0.00
71.99
99.54
123.03
99.01
153.73
230.92
270.48
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
15.51
13.93
12.07
13.75
11.56
10.69
10.14
9.55
8.76
7.48
Current Liabilities
214.11
320.03
359.77
355.35
311.04
361.60
348.25
401.91
298.61
264.85
Trade Payables
162.75
148.71
179.56
133.77
121.87
112.24
83.13
140.11
86.11
99.15
Other Current Liabilities
33.36
153.93
162.35
200.56
160.75
160.69
178.59
194.50
118.92
85.47
Short Term Borrowings
14.95
13.19
13.21
16.42
24.92
85.21
82.67
63.19
90.60
77.85
Short Term Provisions
3.04
4.19
4.66
4.60
3.50
3.47
3.85
4.12
2.97
2.37
Total Liabilities
338.00
298.02
346.91
283.54
275.33
282.68
269.36
408.55
387.87
395.75
Net Block
166.82
167.11
167.11
167.38
163.90
172.36
178.33
186.34
180.27
164.05
Gross Block
248.41
239.29
226.95
215.98
203.10
202.03
198.61
196.65
325.72
305.65
Accumulated Depreciation
81.58
72.18
59.84
48.59
39.20
29.66
20.28
10.32
145.46
141.60
Non Current Assets
178.71
174.24
173.71
182.28
181.69
184.53
191.66
216.83
223.94
214.65
Capital Work in Progress
3.01
1.61
2.35
11.01
13.89
8.97
10.05
9.58
14.42
18.52
Non Current Investment
0.03
0.01
0.01
0.01
0.01
0.02
0.02
0.03
0.01
0.01
Long Term Loans & Adv.
5.42
5.03
3.80
3.40
3.80
3.11
2.84
20.46
28.98
31.08
Other Non Current Assets
3.44
0.49
0.44
0.46
0.10
0.07
0.41
0.43
0.26
0.99
Current Assets
159.29
121.81
171.24
97.53
93.64
98.15
77.70
191.73
163.93
181.11
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
36.02
21.99
49.73
24.85
12.26
19.33
13.07
34.23
34.61
33.77
Sundry Debtors
89.44
68.98
62.80
34.47
50.79
44.41
29.46
84.66
74.94
98.52
Cash & Bank
5.90
3.93
25.31
11.70
16.70
5.25
6.21
9.37
7.22
12.03
Other Current Assets
27.92
3.97
5.40
23.09
13.89
29.16
28.96
63.47
47.15
36.78
Short Term Loans & Adv.
21.27
22.94
28.00
3.42
4.47
2.69
6.27
37.16
29.41
16.51
Net Current Assets
-54.82
-198.22
-188.53
-257.82
-217.41
-263.44
-270.55
-210.19
-134.68
-83.74
Total Assets
338.00
296.05
344.95
279.81
275.33
282.68
269.36
408.56
387.87
395.76

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
3.98
19.80
40.52
16.68
44.13
29.73
32.49
43.39
43.05
40.17
PBT
56.34
-10.29
81.13
-12.41
64.67
-24.98
-32.39
62.40
-7.15
4.48
Adjustment
16.05
37.01
-43.68
33.22
-41.41
42.90
39.71
-37.29
47.85
22.65
Changes in Working Capital
-68.23
-6.75
3.24
-3.00
20.90
11.88
26.05
18.33
2.36
13.13
Cash after chg. in Working capital
4.16
19.97
40.69
17.81
44.16
29.80
33.37
43.43
43.07
40.25
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-0.18
-0.17
-0.16
-1.13
-0.03
-0.06
-0.89
-0.04
-0.01
-0.08
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-16.63
-8.84
0.59
8.04
63.66
-3.07
-1.39
-13.06
-19.63
-5.33
Net Fixed Assets
-10.52
-11.60
-2.31
-10.00
-5.99
-2.34
-2.43
133.91
-15.98
-1.45
Net Investments
-0.02
0.00
0.00
0.00
0.01
0.00
0.01
-0.02
0.00
0.00
Others
-6.09
2.76
2.90
18.04
69.64
-0.73
1.03
-146.95
-3.65
-3.88
Cash from Financing Activity
14.55
-31.99
-28.58
-17.39
-107.87
-26.78
-33.26
-26.93
-28.07
-29.54
Net Cash Inflow / Outflow
1.91
-21.03
12.52
7.34
-0.08
-0.13
-2.16
3.39
-4.65
5.29
Opening Cash & Equivalents
1.49
22.53
10.00
2.66
2.74
2.87
5.03
1.63
6.28
0.99
Closing Cash & Equivalent
3.40
1.49
22.53
10.00
2.66
2.74
2.87
5.03
1.63
6.28

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
6.44
-10.57
-7.55
-62.60
-57.48
-88.32
-77.97
-66.01
-112.21
-109.34
ROA
17.60%
-3.22%
25.85%
-4.51%
23.10%
-9.00%
-9.44%
15.57%
-1.82%
0.80%
ROE
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
ROCE
101.15%
29.82%
428.78%
87.61%
444.45%
50.26%
-2.00%
70.48%
15.27%
13.85%
Fixed Asset Turnover
2.38
2.18
2.32
1.88
1.83
2.08
2.00
1.70
1.37
0.83
Receivable days
49.78
47.23
34.50
39.45
46.85
32.42
52.61
65.66
72.98
144.54
Inventory Days
18.23
25.70
26.45
17.17
15.54
14.22
21.80
28.32
28.77
49.39
Payable days
187.82
197.43
190.42
210.79
243.11
106.12
125.89
110.93
100.14
182.52
Cash Conversion Cycle
-119.82
-124.50
-129.47
-154.17
-180.72
-59.49
-51.47
-16.96
1.60
11.41
Total Debt/Equity
5.21
-1.86
-2.72
-1.02
-1.14
-1.11
-1.19
-1.76
-1.67
-1.74
Interest Cover
2.93
0.52
4.94
0.46
2.97
0.37
-0.05
2.76
0.78
1.24

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Wanbury to launch two new products
    24th Mar 2025, 16:48 PM

    The company is commencing supply of Ketamine during this month with export for European markets

    Read More
  • Wanbury - Quarterly Results
    12th Feb 2025, 20:45 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.